Pasithea Therapeutics Stock (NASDAQ: KTTA) stock price, news, charts, stock research, profile.
Open | $4.68 |
Close | $4.42 |
Volume / Avg. | 9.40K / 15.56K |
Day Range | $4.42 - $4.80 |
52 Wk Range | 3.61 - 17.40 |
Market Cap | $4.68M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 0.52% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pasithea Therapeutics (NASDAQ:KTTA) through any online brokerage.
Other companies in Pasithea Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX) and Palisade Bio (NASDAQ:PALI).
Pasithea Therapeutics has a consensus price target of $2.00.
The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $4.4835 last updated September 20, 2024 at 5:52 PM EDT.
There are no upcoming dividends for Pasithea Therapeutics.
Pasithea Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Pasithea Therapeutics.
Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.